Perioperative safety and efficacy of gluteal muscle contracture release: a randomized controlled trial.

Perioperative safety and efficacy of gluteal muscle contracture release

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039216

Enrollment

Unknown

Registered

2020-10-22

Start date

2020-10-15

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gluteal muscle contracture

Interventions

control group:Topical use of Tranexamic acid before suturing incision during operation

experimental group:Tranexamic acid was given intravenously before operation and topical use before suturing incision during operation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients with muscle contracture around the hip joint need to be treated with muscle release around the hip joint; 2. Female patients with hemoglobin level higher than 120g / L and male patients with hemoglobin level higher than 130g / l will be included in this standard.

Exclusion criteria

Exclusion criteria: 1. Patients with active infection foci in the body; 2. Patients with hypertension, diabetes, tumor diseases and blood diseases; 3. Subjects with a history of allergy to tranexamic acid; 4. Those with hemoglobin levels greater than 150 g / L.

Design outcomes

Primary

Measure	Time frame
blood loss;	—

Countries

China

Contacts

Public ContactBin Shen

West China Hospital of Sichuan University

dr.majun@foxmail.com+86 18980601390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026